ArticleChinese medical journal2026

Nusinersen effectiveness and safety in children with type II/III 5q-spinal muscular atrophy: Second interim analysis from a Chinese disease registry.

Xiuxia Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.